Clinical Trial Update: Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating growth kinetics of sporadic angiomyolipomas while on everolimus has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiomyolipoma
• Sporadic Angiomyolipoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Sporadic Angiomyolipomas (AMLs) | Phase 2 | Status: TERMINATED | Results posted: 2021-02-17